Skip to main content
Premium Trial:

Request an Annual Quote

'One More Piece in the Puzzle'

Premium

In a new study in Cancer Research, researchers at the University of California, San Diego, and their collaborators report that they identified a biomarker for early pancreatic cancer, reports ABC News' Mikaela Conley. The kinase PEAK1 is activated early in the development of pancreatic cancer, the researchers found, and they were able to detect it in biopsies of malignant tumors at every stage in humans as well as in mouse models.

"This study is just one more piece in the puzzle; however, it is probably just a small piece, but still contributes to our understanding as to what drives pancreatic cancer," the University of Nebraska Medical Center's Aaron Sasson tells Conley. "The importance in understanding how pancreatic cancer develops is critical if we are ever going to develop effective treatments for this deadly disease." Conley adds that the data is preliminary, and it is unclear whether this biomarker will have any clinical relevance for patients.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.